Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial In Trauma Patients Remains On FDA Hold
Biopure Corporation (Nasdaq: BPUR) announced that the Food and Drug Administration has advised the U.S. Naval Medical Research Center (NMRC) by letter that it may not initiate a clinical trial of Biopure"s oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under a proposed protocol submitted to the FDA in March 2009. As previously announced, the study, "Restore Effective Survival in Shock" (RESUS) was first proposed and submitted to the FDA in 2005. The proposed trial was placed on clinical hold at that time. It has been resubmitted repeatedly in response to FDA comments and to address comments made by the FDA Blood Products Advisory Committee at an open meeting held in December 2006. Each subsequent submission, including the most recent, was placed on clinical hold.
generic viagra online
Kaiser Permanente Survey Shows Seniors Embrace Internet To Manage Their Health
New data show that Medicare beneficiaries registered to use My Health Manager, Kaiser Permanente"s personal health record, are overwhelmingly satisfied with using the Internet to manage their health care online. Results from the recent Kaiser Permanente survey examining Web site usage and Medicare beneficiary satisfaction were presented today at the World Health Care Congress" 5th Annual Leadership Summit on Medicare in Washington, D.C.
plastic surgery before after
News of the day
MU Public Health Program Receives Grant To Combat Human Trafficking
After drug dealing, trafficking of humans is tied with arms dealing as the second largest criminal industry in the world, and it is the fastest growing, according to the U.S. Department of Health and Human Services (HHS). Recently, HHS awarded more than $2 million in grants to state and local organizations, including the University of Missouri, to identify and help victims of human trafficking.
Health Insurance

International Conference On Reproductive Science To Be Held In Pittsburgh July 18 To 22

Many of the diseases that we develop as adults likely began in our mothers" wombs. This provocative idea and others-including the causes of infertility, the impact of the environment on maternal and fetal health, and new approaches to unraveling the molecular pathways that guide reproduction-will be among the topics discussed at the 42nd annual meeting of the Society for the Study of Reproduction (SSR), which runs from July 18 to 22 at the David L. Lawrence Convention Center, downtown Pittsburgh. The concept that the stage for diseases in adulthood could be set early in fetal development is intriguing, and perhaps even intimidating, said SSR president Asgerally T. Fazleabas, Ph.D., of the University of Illinois College of Medicine in Chicago. But, he noted, the same rationale also says that a healthy life must begin in the womb. "Learning as much as we can about this critical time in development, and the influences upon it, has great potential for enhancing well-being at all ages," Dr. Fazleabas said. "More than 900 scientists, graduate students and post-doctoral trainees from 33 countries are expected to attend our Pittsburgh meeting, and we are all focused on understanding the science of reproduction, fertility and embryonic development." The keynote address, "Chronic Disease Begins in the Womb," will be delivered at 4 p.m., Saturday, July 18, by David J.P. Barker, M.D., Ph.D., Oregon Health & Science University and University of Southampton, after welcoming remarks from Dr. Fazleabas; Program Committee Chair Patricia Hunt, Ph.D., of Washington State University; and local chair Tony M. Plant, Ph.D., of the University of Pittsburgh School of Medicine. From Sunday, July 19 through Tuesday, July 21, morning sessions will include panels of experts discussing the latest research findings on a range of topics, such as fertility preservation, maternal effects on egg quality, new concepts in sperm function and fertility, and the genetic control of the reproductive process. State-of-the-art lectures will be presented in the afternoons by outstanding scientists working on the impact of obesity and reproductive health, the impact of the environment on reproductive cancers, and the potential of micro RNA therapy for diseases such as diabetes and other endocrine-associated diseases. The meeting concludes Wednesday, July 22, after a morning of scientific sessions. University of Pittsburgh School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009